Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2003
09/17/2003CN1442479A Mammalian engineering cell line for production of hantan virus granules
09/17/2003CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide
09/17/2003CN1121408C Plasmid DNA, its process for preparing medical composition and use thereof
09/16/2003US6620925 Recombinant nucleic acid encoding proteins associated with apoptin; use in diagnosis and treatment of autoimmune diseases, tumors and cancer
09/16/2003US6620923 Use for treatment of uterine cancer
09/16/2003US6620914 Transcription factor islet-brain 1 (IB1)
09/16/2003US6620912 Novel human protein of given nucleotide sequence; vectors, host cells, antibodies, and recombinant methods; for diagnosis and treatment of disorders including those in the immune system
09/16/2003US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary
09/16/2003US6620618 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines
09/16/2003US6620617 Gene encapsulated in polymer; sustained release
09/16/2003US6620603 Human mitogenic oxidase
09/16/2003US6620595 Retroviral vectors comprising an enhanced 3′ transcription termination structure
09/16/2003US6620594 Uncoupling protein homologue: UCP 3
09/16/2003CA2103371C Targeted delivery of genes encoding secretory proteins
09/12/2003WO2003074736A1 Diagnostics and remedies for malignant brain tumor
09/12/2003WO2003074735A1 Diagnostic method for glaucoma
09/12/2003WO2003074712A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
09/12/2003WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074692A2 Specific gene expression in colonic cancer cell lines
09/12/2003WO2003074689A1 Treatment of staphylococcus infections using transgenic expression of a modified lysostaphin gene
09/12/2003WO2003074685A2 Il-10 gene transfer to peripheral blood mononuclear cells
09/12/2003WO2003074682A1 Bacterial spores
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074565A2 Peptides for use in antitumor immunotherapy
09/12/2003WO2003074561A1 A method for treating allergic disease and asthma by recombinant adenovirus-and adeno-associated virus-mediated ifn-ϝ gene
09/12/2003WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003073998A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073981A2 Novel of cytokine inhibitors
09/12/2003WO2003073918A2 Prevention of recurrence and metastasis of cancer
09/12/2003WO2003066674A3 Viral cd30 polypeptide
09/12/2003WO2003047525A3 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
09/12/2003WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof
09/12/2003WO2003038034A3 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
09/12/2003WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002040059A3 Methods and compositions for inducing cell-mediated immune responses
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2001090382A3 Fas ligand-fused proteins
09/12/2003WO2001090197A9 Synthetic peptides and uses therefore
09/12/2003CA2478378A1 Novel use of cytokine inhibitors
09/12/2003CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003CA2477762A1 Peptides for use in antitumor immunotherapy
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477647A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
09/12/2003CA2477596A1 Treatment of staphylococcus infections
09/12/2003CA2477411A1 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/12/2003CA2477406A1 Dna vaccine against proliferating endothelial cells and methods of use thereof
09/12/2003CA2476724A1 Prevention of recurrence and metastasis of cancer
09/12/2003CA2476410A1 Methods to increase or decrease bone density
09/12/2003CA2475690A1 Diagnostic method for glaucoma
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003073995A2 Dna vaccine against proliferating endothelial cells and methods of use thereof.
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030171566 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171551 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171496 Drug delivery compositions and medical devices containing block copolymer
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171336 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1
09/11/2003US20030171335 Antisense antiviral agent and method for treating ssRNA viral infection
09/11/2003US20030171328 Non-invasive method for detecting target-RNA
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171322 Counterions of polycations used to compact nucleic acids profoundly affect shape and stability of particles formed. Shape is associated with differential serum nuclease resistance and colloidal stability. A surrogate for
09/11/2003US20030171320 Methods for treating ocular neovascular diseases
09/11/2003US20030171319 Human chemokine beta-10 mutant polypeptides
09/11/2003US20030171316 Use of prohibitin RNA in treatment of cancer
09/11/2003US20030171314 Early protection of susceptible animals against foot and mouth disease (FMD) may be achieved by inoculating the animals with a vaccine comprising an interferon DNA sequence. One day after inoculation, animals have been found protected from
09/11/2003US20030171295 Drug screening assays, and diagnostic and therapeutic methods for the treatment of body weight disorders, such as obesity, anorexia and cachexia, utilizing the melanocortin 4-receptor (MC4-R) as the target for intervention
09/11/2003US20030171287 Medicinal compositions for angiogenic therapy
09/11/2003US20030171279 Methods and composition concerning herpesvirus Us3 and BAD-involved apoptosis
09/11/2003US20030171273 DNA of SEQ ID NO:1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the beta -globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1.
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030171266 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
09/11/2003US20030171252 Nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for human
09/11/2003US20030170898 Method for intracellular modifications within living cells using pulsed electric fields
09/11/2003US20030170897 Virus vector for transferring gene into renal cells
09/11/2003US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products
09/11/2003US20030170895 Methods of making hypermutable cells using PMSR homologs
09/11/2003US20030170894 Tryptophan containing low molecular weight polylysine, for use in receptor-mediated and nonreceptor-mediated gene delivery, both in vivo and in vitro
09/11/2003US20030170885 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy
09/11/2003US20030170871 Alphavirus-based vectors for persistent infection
09/11/2003US20030170866 Novel cyclin-selective ubiquitin carrier polypeptides
09/11/2003US20030170862 Nuclear factor kappaB inducing factor
09/11/2003US20030170856 Regulation of human map kinase phosphatase-like enzyme
09/11/2003US20030170841 Novel molecules of the pyrin domain protein family and uses thereof
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170838 Novel polynucleotides and polypeptides encoded thereby
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 870